IRIS
NATILE, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.923
AS - Asia 5.227
EU - Europa 3.372
SA - Sud America 1.377
AF - Africa 131
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
Totale 27.050
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.796
SG - Singapore 2.167
CN - Cina 1.645
BR - Brasile 1.191
SE - Svezia 813
HK - Hong Kong 745
RU - Federazione Russa 549
UA - Ucraina 446
DE - Germania 356
IT - Italia 331
FI - Finlandia 316
GB - Regno Unito 246
VN - Vietnam 243
IN - India 92
AR - Argentina 66
FR - Francia 60
CA - Canada 56
BD - Bangladesh 49
BE - Belgio 47
ID - Indonesia 46
IQ - Iraq 46
MX - Messico 46
IE - Irlanda 42
CI - Costa d'Avorio 41
EC - Ecuador 34
ZA - Sudafrica 34
JP - Giappone 31
TR - Turchia 31
ES - Italia 29
PL - Polonia 26
VE - Venezuela 25
AT - Austria 24
NL - Olanda 18
CZ - Repubblica Ceca 17
IR - Iran 17
MA - Marocco 17
CO - Colombia 16
PK - Pakistan 15
SA - Arabia Saudita 15
AU - Australia 14
CL - Cile 14
PY - Paraguay 14
TN - Tunisia 13
KE - Kenya 11
JO - Giordania 10
KZ - Kazakistan 9
LT - Lituania 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 7
PT - Portogallo 6
UY - Uruguay 6
AL - Albania 5
AZ - Azerbaigian 5
BG - Bulgaria 5
EG - Egitto 5
HU - Ungheria 5
IL - Israele 5
JM - Giamaica 5
PA - Panama 5
PE - Perù 5
BH - Bahrain 4
BO - Bolivia 4
CR - Costa Rica 4
DZ - Algeria 4
MY - Malesia 4
NG - Nigeria 4
SK - Slovacchia (Repubblica Slovacca) 4
DO - Repubblica Dominicana 3
EU - Europa 3
HR - Croazia 3
KR - Corea 3
LB - Libano 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
GR - Grecia 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MM - Myanmar 2
OM - Oman 2
PR - Porto Rico 2
PS - Palestinian Territory 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CG - Congo 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
GE - Georgia 1
GI - Gibilterra 1
GL - Groenlandia 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
Totale 27.038
Salva come PNG Salva come JPEG
Città #
Fairfield 2.572
Woodbridge 1.714
Ashburn 1.478
Chandler 1.282
Houston 1.164
Seattle 1.049
Singapore 1.010
Jacksonville 974
Cambridge 882
Wilmington 782
Hong Kong 738
Nyköping 655
Ann Arbor 610
Beijing 355
Nanjing 355
Lawrence 287
Roxbury 283
New York 233
Boardman 206
Princeton 186
Des Moines 173
Bari 155
Dallas 139
Los Angeles 133
Brooklyn 119
San Diego 105
Nanchang 103
Dearborn 101
Inglewood 98
Ho Chi Minh City 95
São Paulo 92
Shenyang 84
Jiaxing 75
Santa Clara 75
Buffalo 73
Hebei 72
Helsinki 62
Tianjin 50
Rio de Janeiro 49
Brussels 47
Hanoi 47
Abidjan 41
London 39
Moscow 39
Kunming 38
Munich 38
Dublin 37
Changsha 35
Chicago 32
Jinan 32
Tokyo 29
Pune 27
San Francisco 27
Shanghai 27
Guangzhou 25
Paris 25
Curitiba 24
Jakarta 23
Baghdad 22
San Mateo 22
The Dalles 22
Washington 22
Wuhan 22
Zhengzhou 22
Columbus 21
Warsaw 21
Stockholm 20
Council Bluffs 19
Johannesburg 19
Belo Horizonte 18
Mexico City 17
Norwalk 17
Brasília 16
Brno 16
Boston 15
Mumbai 15
Montreal 14
Quito 14
Ardabil 13
Atlanta 13
Leawood 13
Toronto 13
Ningbo 12
Porto Alegre 12
Denver 11
Lanzhou 11
Monmouth Junction 11
Salvador 11
Sorocaba 11
Amman 10
Ankara 10
Augusta 10
Campinas 10
Charlotte 10
Chennai 10
Falls Church 10
Hefei 10
Nuremberg 10
Phoenix 10
Salt Lake City 10
Totale 19.915
Salva come PNG Salva come JPEG
Nome #
Anticancer potential of a photoactivated transplatin derivative containing the methylazaindole ligand mediated by ROS generation and DNA cleavage 196
Amyloid Transition of Ubiquitin on Silver Nanoparticles Produced by Pulsed Laser Ablation in Liquid as a Function of Stabilizer and Single-Point Mutations 194
Anticancer kiteplatin pyrophosphate derivatives show unexpected target selectivity for DNA 176
A Pt(IV) prodrug of kiteplatin with the bone-targeting pyrophosphate ligand 173
Mechanistic and structural basis for inhibition of copper trafficking by platinum anticancer drugs 168
A model radiopharmaceutical agent targeted to translocator protein 18 kDa (TSPO) 163
Cytotoxicity-boosting of kiteplatin by Pt(IV) prodrugs with axial benzoate ligands 162
Activation of platinum(IV) prodrugs by cytochrome c and characterization of the protein binding sites 159
Addition versus substitution in the reaction of diiodo(2,9-dimethyl-1,10-phenanthroline)platinum(II) with aromatic bases. X-ray crystal structures of the substitution products with 2-amino-pyridine and 1-methyl-cytosine 158
A new case of polymorphism in platinum(II) complexes: [PtBr2(2,9-dimethyl-1,10-phenanthroline)]? 157
Silver and gold nanoparticles produced by pulsed laser ablation in liquid to investigate their interaction with Ubiquitin 143
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 143
Bisphosphonate complexation and calcium doping in silica xerogels as a combined strategy for local and controlled release of active platinum antitumor compounds 142
Encapsulation of lipophilic kiteplatin Pt(IV) prodrugs in PLGA-PEG micelles 142
Activation of Ketones by Electrophilic Metal Complexes. Synthesis of Some Ketonyl Platinum(II) Complexes and X-Ray Crystal Structure of [PtCl{CH2C(O)CH3}(1,10-phenanthroline)]·1/2Y (Y = H2O or CH2Cl2) 141
Aggregation Pathways of Native-Like Ubiquitin Promoted by Single-Point Mutation, Metal Ion Concentration, and Dielectric Constant of the Medium 140
Addition of Hydroxide, Alkoxide, and Carboxylate Anions to Platinum-bonded Ethylene 139
Antiviral properties and cytotoxic activity of platinum(II) complexes with 1,10-phenanthrolines and acyclovir or penciclovir 139
Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs. 137
A new dinuclear platinum complex with a nitrogen-containing geminal bisphosphonate as potential anticancer compound specifically targeted to bone tissues 137
Isomerism of amides coordinated to platinum. X-ray crystal structure of dichloro-bisacetamide-platinum(II) 137
Copper binding to naturally occurring, lactam form of angiogenin differs from that to recombinant protein, affecting their activity 136
A NMR, X-ray, and DFT combined study on the regio-chemistry of nucleophilic addition to platinum(II) coordinated terminal olefins 135
Lantern-Shaped” Platinum(III) Complexes with Axially Bound 9-Ethylguanine or 1-Methylcytosine (L) of General Formula [Pt2{HN=C(But)O}4L2](NO3)2 135
Insertion of terminal alkyne into Pt-N bond of the square planar [PtI2(Me2phen)] complex 135
Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione 130
A General Procedure for the Selective Oxidation of Sulfides to Sulfoxides by Nitric Acid: Tetrabromoaurate(III) Catalyst in a Biphasic System 129
DNA fragment conformations in adducts with Kiteplatin 129
Dual-acting antitumor Pt(iv) prodrugs of kiteplatin with dichloroacetate axial ligands 129
Effect of chirality in platinum drugs 129
C hiral Discrimination in Platinum Anticancer Drugs 127
A Seven-Membered Platinum-Amino-Amidine Metallacycle. X-ray Structure of cis-[Pt(NH=CPhNButCH2CH2NHBut)Cl2].´Me2CO 127
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 127
Chemical and cellular investigations of trans-ammine-pyridine-dichlorido-platinum(II), the likely metabolite of the antitumor active cis-diammine-pyridine-chorido-platinum(II) 126
Novel Kiteplatin Pyrophosphate Derivatives with Improved Efficacy 125
Hydroxyapatite nanocrystals as a smart, pH sensitive, delivery system for kiteplatin 125
Chiral discrimination in the formation reaction and at equilibrium for N,N,N ',N '-tetramethyl-1,2-diaminocyclohexane-PtG(2) complexes 124
Synthesis and X-ray Structural Characterization of Two Unbridged Diplatinum(III) Compounds: cis- and trans-Bis[bis(1-imino-1-methoxyethane)trichloroplatinum(III)]. Transient Species in the Oxidation of Platinum(II) to Platinum(IV) 123
Reaction of Histone H1 with trans-Platinum Complexes and the Effect on DNA Platination 123
Computational metallomics of the anticancer drug cisplatin 123
Cationic intermediates in oxidative addition reactions of Cl2 to [PtCl2(cis-1,4-DACH)] 122
Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position 121
Cisplatin reacts with histone H1 and the adduct forms a ternary complex with DNA 121
Biomimetic hydroxyapatite/drug nanocrystals as potential bone substitutes with anti-tumour drug delivery properties 120
Atropisomerization of cis-Bis(5'GMP)-Platinum(II)-Diamine complexes with Non-C2-symmetrical asymmetric diamine ligands containing NH groups directed to one side of the coordination plane 120
Conformer distribution in (cis-1,4-DACH)bis(guanosine5'-phosphate)platinum(II) adducts: a reliable model for DNA adducts of antitumoral cisplatin 119
Synthesis and characterization of a platinum(II) complex tethered to a ligand of the peripheral benzodiazepine receptor 118
The First Example of a Dinuclear Platinum(III) Complex with Three Bridging Ligands 117
Cytotoxic trans-oriented iminoether platinum complexes – Kinetics of binding to DNA oligonucleotides determined by 15N NMR spectroscopy 117
The reaction of a platinated methionine motif of CTR1 with cysteine and histidine is dependent upon the type of precursor platinum complex 117
Platinum(IV) complexes of trans-1,2-diamino-4-cyclohexene: Prodrugs affording an oxaliplatin analogue that overcomes cancer resistance 117
Cytotoxic trans-oriented platinum complexes only form adducts with single-stranded oligodeoxynucleotides 116
NMR and X-ray characterization of a platinum(II) complex with (−)sparteine 116
Single-Stranded Oligonucleotide Adducts Formed by Pt Complexes Favoring Left-Handed Base Canting: Steric Effect of Flanking Residues and Relevance to DNA Adducts Formed by Pt Anticancer Drugs 116
An Updated View of Cisplatin Transport 115
NMR and X-ray Structural Characterization of a Cisplatin Analogue Able To Slow Down the Pt−N7 Rotation of a Coordinated Guanine Base by a Billion-Fold Times: 2,2'-Bipiperidine(dimethylmalonato)platinum(II) Complex 114
Insights into the Molecular Mechanisms of Protein Platination from a Case Study: The Reaction of Anticancer Platinum(II) Iminoethers with Horse Heart Cytochrome c 114
Synthesis and Characterization of Platinum(II) Complexes of Diethyl [(Methylsulfinyl)methyl]phosphonate: Potential Drugs against Bone Tumors 114
A new polymorph of dichlorido(1,10-phenanthroline)platinum(II) 114
A Molecular Tool for Measuring the Electron-Acceptor Ability of Ligands from Crystallographic Data 114
Potentiation of cytotoxic action of cis-[PtCl2(NH3)(1M7AI)] by UVA irradiation. Mechanistic insights 114
Aiding Factors in the Formation of Azaplatinacyclobutane Rings – X-ray and Crystal Structure of [Pt{CH(Ph)CH2NEt2-κC,κN}(N,N,N′,N′-tetramethylethylenediamine)]+ and of Its Open-Chain Precursor 114
Cytotoxicity, mutagenicity, cellular uptake, DNA and glutathione interactions of lipophilic trans-platinum complexes tethered to 1-adamantylamine 113
Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone Atox1 in aqueous solution 113
Dependence of the Reduction Products of Platinum(IV) Prodrugs upon the Configuration of the Substrate, Bulk of the Carrier Ligands, and Nature of the Reducing Agent 113
Platinum Complexes with the Novel Ligand Diethyl [(Methylsulfinyl)- methyl]phosphonate (SMP): Solid-State Characterization of Potassium Trichloro(SMP)platinum(II) which, in Solution, Gives Dichloro(SMP)- platinum(II) and Potassium Chloride 113
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 113
One-Pot Synthesis of New Organometallic Compounds with Platinum-Carbon Bond 113
Reactivity of kiteplatin with S-donor biomolecules and nucleotides 112
Copper Homeostasis in Humans and Bacteria 112
C60@Lysozyme: Direct Observation by Nuclear Magnetic Resonance of a 1:1 Fullerene Protein Adduct 112
Endocyclic versus exocyclic N-coordination to platinum(II) of some nitro-9-[(2-dialkylaminoethyl)amino]acridines 111
A novel head-to-head conformer of d(GpG) cross-linked by Pt: New light on the conformation of such cross-links formed by Pt anticancer drugs 111
Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours 110
Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1 110
Platinum amides from platinum nitriles: X-ray crystal structure of trans-dichloro-bis(1-imino-1-hydroxy-2,2-dimethylpropane)platinum(II) 109
Multi-Acting Mitochondria-Targeted Platinum(IV) Prodrugs of Kiteplatin with α-Lipoic Acid in the Axial Positions 108
Translocation of Platinum Anticancer Drugs by Human Copper ATPases ATP7A and ATP7B 107
An updated view of translocator protein (TSPO) 107
Cytotoxicity, cellular uptake, glutathione and DNA interactions of an antitumor large-ring PtII chelate complex incorporating the cis-1,4-diaminocyclohexane carrier ligand 107
H/D exchange at sp(3) carbons in the coordination sphere of platinum(II) 106
X-ray structure and circular dichroism of pure rotamers of Bis[Guanosine-5'-monophosphate(-1)](N,N,N',N'-tetramethylcyclohexyl-1,2-diamine)platinum(II) complexes that have R,R and S,S configurations at the asymmetric diamine 106
Platinum(II) complexes with the diethyl(aminomethyl)phosphonate ligand (amp): characterization, properties and unusual solution behavior 106
Synthesis and characterisation of the amidine complexes trans-[PtCl(NH3){HN=C(NH2)R}2]Cl (R = Me, Ph, CH2Ph) derived from addition of NH3 to the coordinated nitriles in trans-[PtCl2(NCR)2] 105
Antitumor trans Platinum Complexes can Form Cross-Links with Adjacent Purine Groups 105
Mono- and bis-guanosine adducts of platinum complexes with carrier ligands having in-plane steric bulk: The case of 1,10-phenanthroline and 2,9-dimethyl-1,10-phenanthroline 105
Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(II) and rhenium(I) with a ligand targeting the translocator protein (TSPO) 105
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 104
Insertion of alkynes into Pt-X bonds of square planar [PtX2(N-N)] (X = Cl, Br, I) complexes 104
Structural Determinants of Cisplatin and Transplatin Binding to the Met-Rich Motif of Ctr1: A Computational Spectroscopy Approach 104
Chirality-Controlling Chelate (CCC) Ligands in Analogs of Platinum Anticancer Agents. Influence of N9 Substituents of Guanine Derivatives (G) on the Distribution of Chiral Conformers of (CCC)PtG2 with CCC = N,N'-Dimethyl-2,3-diaminobutane 104
null 104
Fourier transform infrared spectroscopy Part V. Vibrational studies on phenanthroline-perchloric acid complexes 102
Contribution of H-Bonding to the Preference of Platinum Anti-Tumour Drugs for Particular Bases and Particular Cross-Links 102
Unusual reactivity at a platinum center determined by the ligands and the solvent environment 102
Synthesis and structural characterization of isomeric "lantern-shaped" platinum(III) complexes of formula [Pt2(PPh3)X{N(H)C(R)O}4](NO3)2 (X=PPh3, H2O) 102
Five-coordinate alkene complexes of palladium(II) and platinum(II) 101
Role of metal ions and hydrogen bond acceptors in the tautomeric equilibrium of nitro-9[(alkylamino)amino]-acridine drugs 101
Conformational Selection of Ubiquitin Quaternary Structures Driven by Zinc Ions 101
Influence of steric and electronic factors in the stabilization of five-coordinate ethylene complexes of platinum(II): X-ray crystal structure of [PtCl2(2,9-dimethyl-1,10-phenanthroline-5,6-dione)] 101
Totale 12.317
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.624
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.682 0 0 0 0 0 141 214 222 266 452 234 153
2021/20222.087 71 284 21 72 94 157 94 113 203 156 359 463
2022/20233.338 568 310 207 326 440 400 22 406 502 19 82 56
2023/20241.087 95 173 46 91 104 295 28 64 16 21 5 149
2024/20253.983 175 67 379 132 104 298 339 301 175 196 552 1.265
2025/20264.044 1.151 406 512 972 863 140 0 0 0 0 0 0
Totale 27.487